The Cloudbased Drug Discovery Platform Market To Sail Through Innovation-Based Turbulence

Published On : 11/25/2021

A new report by Persistence Market Research presents interesting facets of the global cloud-based drug discovery platform market and provides value forecasts for an eight year period from 2017 to 2025. The report titled ‘Cloud-based Drug Discovery Platform Market: Global Industry Analysis (2012 – 2016) and Forecast (2017–2025)’ is a comprehensive take on the global cloud-based drug discovery platform market and highlights the different factors anticipated to impact market revenue growth during the said period. According to Persistence Market Research estimations, the global cloud-based drug discovery platform market is projected to be valued at US$ 1,601.1 Mn by the end of 2017 and is expected to reach a market valuation of US$ 4,323.5 Mn by the end of the forecast period in 2025, witnessing a CAGR of 13.2% in terms of value during the forecast period.

Strategizing The Moves For The Next Decade? See Through Sample Of Cloudbased Drug Discovery Platform Market Report! https://www.persistencemarketresearch.com/samples/11020

Company Profiles:

• IBM Corporation
• Accenture PLC
• Tata Consultancy Services Limited
• SAS Institute Inc.
• BioXcel Corporation
• Cloud Pharmaceuticals Inc.
• WuXi AppTec (Sanghai) Co. Ltd.
• Dassault System
• Acelot, Inc.

Starting With The New Decade On A Diligent Note In The Cloudbased Drug Discovery Platform Market? https://www.persistencemarketresearch.com/methodology/11020

Global Cloud-based Drug Discovery Platform Market: Dynamics

Revenue drivers

• Increasing adoption of cloud-based platforms in the healthcare industry to enhance research efficiency
• Traction in the adoption of machine learning and artificial intelligence for drug discovery
• Regional healthcare companies adopting cloud-based technologies for collaboration with international healthcare market players

Growth challenges

• Concerns regarding infrastructure compatibility issues
• Issues pertaining to interoperability of applications with devices

Market trends

• Upsurge in the implementation of cloud-based platforms in the healthcare sector across the North America region
• Rising adoption of cloud-based mobile applications for collaborative drug discovery

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others. Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a CAGR of 13.4%. Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of US$ 1,247.8 Mn by the end of 2025.

How About Obtaining Insights About The Region To Enter Concerning The Cloudbased Drug Discovery Platform Market? Press The “Purchase Now” Button To Have Our Cloudbased Drug Discovery Platform Market Report! https://www.persistencemarketresearch.com/checkout/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period. The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a CAGR of 16.7% during the forecast period.

Related Reports:

Healthcare Information Systems Market

Cleanroom Technology Market

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700

Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Uma Rajagopal

Uma Rajagopal has been managing the posting of content for multiple platforms since 2021, including Global Banking & Finance Review, Asset Digest, Biz Dispatch, Blockchain Tribune, Business Express, Brands Journal, Companies Digest, Economy Standard, Entrepreneur Tribune, Finance Digest, Fintech Herald, Global Islamic Finance Magazine, International Releases, Online World News, Luxury Adviser, Palmbay Herald, Startup Observer, Technology Dispatch, Trading Herald, and Wealth Tribune. Her role ensures that content is published accurately and efficiently across these diverse publications.